NCT00380380View on ClinicalTrials.gov

A Study to Assess the Acute Effects of Vildagliptin on Gastric Emptying in Patients With Type 2 Diabetes.

PHASE3CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Vildagliptin

Trial Locations (1)

Unknown

Munich, 81377, Germany, Munich

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY